Tanai Therapeutics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $2.22M

  • Investors
  • 5

Tanai Therapeutics General Information

Description

Developer of orally administered therapeutics designed for fat loss while preserving muscle mass. The company's obesity drugs and combination treatments have a significant impact on weight loss while reducing cardiovascular events, enabling customers to address the problem of obesity and reduce weight.

Contact Information

Website
www.tanaitx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Pieter van Reysschootlaan 2
  • Bus 104
  • 9051 Gent
  • Belgium
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Pieter van Reysschootlaan 2
  • Bus 104
  • 9051 Gent
  • Belgium

Tanai Therapeutics Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tanai Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 19-Sep-2024 $2.22M Completed Startup
1. Seed Round 08-Dec-2023 Completed Startup
To view Tanai Therapeutics’s complete valuation and funding history, request access »

Tanai Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view Tanai Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Tanai Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tanai Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Novo Nordisk Corporation Minority
BioGeneration Ventures Venture Capital Minority
Qbic Fund Venture Capital Minority
V-Bio Ventures Venture Capital Minority
VIB Not-For-Profit Venture Capital Minority
To view Tanai Therapeutics’s complete investors history, request access »

Tanai Therapeutics FAQs

  • When was Tanai Therapeutics founded?

    Tanai Therapeutics was founded in 2023.

  • Where is Tanai Therapeutics headquartered?

    Tanai Therapeutics is headquartered in Gent, Belgium.

  • What is the size of Tanai Therapeutics?

    Tanai Therapeutics has 8 total employees.

  • What industry is Tanai Therapeutics in?

    Tanai Therapeutics’s primary industry is Drug Discovery.

  • Is Tanai Therapeutics a private or public company?

    Tanai Therapeutics is a Private company.

  • What is Tanai Therapeutics’s current revenue?

    The current revenue for Tanai Therapeutics is .

  • How much funding has Tanai Therapeutics raised over time?

    Tanai Therapeutics has raised $6.56M.

  • Who are Tanai Therapeutics’s investors?

    Novo Nordisk, BioGeneration Ventures, Qbic Fund, V-Bio Ventures, and VIB have invested in Tanai Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process